Insulin Aspart + 100IU | Insulin Degludec is a prescription anti-diabetic injection containing a soluble combination of two human insulin analogues: ultra-long-acting insulin degludec and rapid-acting insulin aspart. It is used to improve glycemic control by managing blood sugar levels in adults, adolescents, and children with diabetes mellitus. This dual-action medication provides baseline blood sugar control throughout the day alongside rapid support for mealtime blood sugar spikes in a single subcutaneous injection.
Insulin Aspart + 100IU | Insulin Degludec is an insulin medicine used to help control blood sugar levels in people with diabetes mellitus. It contains insulin degludec, a long-acting insulin, and insulin aspart, a rapid-acting insulin. Together, they help control blood sugar levels both after meals and throughout the day.
This medicine may be prescribed for adults with type 1 or type 2 diabetes when both background and mealtime insulin support are needed. Keeping blood sugar levels within the recommended range is an important part of diabetes care and may help reduce the risk of long-term complications affecting the eyes, kidneys, nerves, heart, and blood vessels.
After injection, insulin aspart starts working quickly to help manage the rise in blood sugar that happens after eating. Insulin degludec works more slowly and provides steady blood sugar control between meals and overnight. The dose is adjusted individually based on blood sugar readings, meals, physical activity, and overall treatment response.
Insulin Aspart + 100IU | Insulin Degludec is given as an injection under the skin (subcutaneous injection) and should be used exactly as prescribed by a doctor or diabetes specialist. Regular blood sugar monitoring is important during treatment. Proper instruction on injection technique, insulin storage, and recognising symptoms of low blood sugar is important before starting treatment.
Insulin Aspart + 100IU | Insulin Degludec may be indicated by your doctor for:
Providing basal and prandial insulin support as part of a daily multi-dose regimen in adults and pediatric patients.
Managing blood glucose levels when oral anti-diabetic medications or lifestyle changes alone no longer provide adequate glycemic control.
Insulin Aspart + 100IU | Insulin Degludec may provide benefits such as:
Consult your doctor if you experience any unusual, severe, or persistent symptoms while using Insulin Aspart + 100IU | Insulin Degludec.
Insulin Aspart + 100IU | Insulin Degludec is used to help control blood sugar levels in people with diabetes mellitus. It contains two forms of insulin that work at different speeds to provide both rapid and long-lasting blood glucose control.
Insulin aspart is a rapid-acting insulin analogue. After injection, it is absorbed quickly and helps lower blood glucose by allowing glucose to move from the bloodstream into muscle and fat cells. It also reduces glucose production by the liver. Its fast action helps control the rise in blood sugar that occurs after meals.
Insulin degludec is a long-acting basal insulin analogue that forms multi-hexamers under the skin after injection, creating a slow and steady release of insulin over time. This provides continuous background insulin activity to help control blood glucose levels between meals and during the night.
Together, these insulins provide mealtime glucose control along with prolonged basal insulin support, helping maintain more stable blood sugar levels throughout the day.
Insulin Aspart + 100IU | Insulin Degludec should not be used in patients with known allergy to insulin degludec, insulin aspart, or any ingredient in the formulation. Seek urgent medical attention if severe allergic reactions occur.
Insulin Aspart + 100IU | Insulin Degludec is generally considered safe during breastfeeding. Insulin treatment is often continued during lactation, although dose adjustments may be needed.
Insulin Aspart + 100IU | Insulin Degludec may be used during pregnancy under medical supervision to maintain blood glucose control. Insulin requirements may change during different stages of pregnancy.
Low blood sugar may reduce concentration and reaction time while using Insulin Aspart + 100IU | Insulin Degludec. Avoid driving if you experience symptoms of hypoglycemia such as sweating, shakiness, confusion, or blurred vision.
Alcohol may increase or mask the warning signs of low blood sugar while using Insulin Aspart + 100IU | Insulin Degludec. Careful blood glucose monitoring is recommended.
Patients with liver disease may have altered insulin requirements and may require closer blood glucose monitoring during treatment with Insulin Aspart + 100IU | Insulin Degludec.
Kidney disease may increase the risk of hypoglycemia because insulin clearance may be reduced. Dose adjustment and regular monitoring may be required.
Insulin Aspart + 100IU | Insulin Degludec should only be used in children if prescribed by a healthcare professional experienced in insulin therapy. Blood glucose should be monitored regularly during treatment.
Older adults may be more sensitive to hypoglycemia and may require careful dose adjustment and monitoring during treatment with Insulin Aspart + 100IU | Insulin Degludec.
If you miss a dose of Insulin Aspart + 100IU | Insulin Degludec, take it with your next main meal of that day, then resume your regular once- or twice-daily dosing schedule.
Do not take a double dose or inject extra units to compensate for a forgotten dose, as doing so can cause a severe drop in blood sugar. If you are unsure how to adjust your schedule after a missed meal, contact your healthcare team for specific instructions.
Therapeutic Class
Antidiabetic Agents / Parenteral Insulins
Action Class
Insulin Receptor Agonist (Glucose Transport and Hepatic Suppression Facilitator)
Chemical Class
Recombinant Human Insulin Analogues (Basal-Prandial Blend)
Habit Forming
No
Checkout Editorial Policy